Company overview
Basic information
Company name
Milveta, UAB
Company code
304322350
VAT code
LT100010330412
Registered address
Telšių r. sav., Ryškėnų sen., Ryškėnų k., Žalioji g. 8, LT-87431
Registration date
2016-08-05
Company age: 10 y. 1 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
UAB "Milveta"
Company code: 304322350
Address: Telšių r. sav., Ryškėnų sen., Ryškėnų k., Žalioji g. 8, LT-87431
VAT code: LT100010330412
Download a detailed company report
Make confident decisions with all the information about Milveta, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Milveta, UAB (company code 304322350) is an operational private limited liability company registered in 2016. It is a privately owned Lithuanian company, with governance described as CEO only, and is classified as a micro company in the national private non-financial companies sector. The company’s authorised capital is EUR 2.5K. Its registered address is in Ryškenu k., Ryškenu sen., Telšiu r. sav., Telšiu apskritis.
The company operates under EVRK code G.47.73.00, retail sale of pharmaceutical products. In 2025, revenue was EUR 20.0K, compared with EUR 24.0K in 2024 and EUR 19.2K in 2023. The company returned to a small net profit in 2025, posting EUR 47 after losses of EUR 14.6K in 2024 and EUR 24.0K in 2023. At the end of 2025, equity remained negative at EUR 63.4K, liabilities were EUR 93.8K, and total assets were EUR 30.4K. Average employment has been stable at 2 employees each year from 2023 to 2026, and so far in 2026 the average workforce remains 2 employees. The latest average annual wage data indicates a small workforce level, with revenue per employee at EUR 10.0K in 2025.
The company operates under EVRK code G.47.73.00, retail sale of pharmaceutical products. In 2025, revenue was EUR 20.0K, compared with EUR 24.0K in 2024 and EUR 19.2K in 2023. The company returned to a small net profit in 2025, posting EUR 47 after losses of EUR 14.6K in 2024 and EUR 24.0K in 2023. At the end of 2025, equity remained negative at EUR 63.4K, liabilities were EUR 93.8K, and total assets were EUR 30.4K. Average employment has been stable at 2 employees each year from 2023 to 2026, and so far in 2026 the average workforce remains 2 employees. The latest average annual wage data indicates a small workforce level, with revenue per employee at EUR 10.0K in 2025.